Evusheld injections can now be used to treat coronavirus disease 2019 (COVID-19). The drug will help reduce severe illness and death from COVID-19 infection by 50-60%.
The Food and Drug Administration (FDA) approved the registration of AstraZeneca Co., Ltd., for Evusheld under a conditional authorization in emergency situations on 27 June 2022, for use in the prevention of COVID-19. And most recently, Evusheld has been added to the indication as an injection to treat COVID-19 for people with mild to moderate symptoms. In adults and adolescents aged 12 years and over with a body weight of at least 40 kilograms, a dose of 600 milligrams originally approved for use to prevent COVID-19.
People should receive Evusheld as soon as possible when the results of COVID-19 infection are known and should receive the drug within seven days after symptom onset.
People who need to use this drug should provide preliminary information to the doctor, such as a history of drug allergies, history of cardiovascular disease treatment, pregnancy, breastfeeding, and any other health conditions.
Source: Food and Drug Administration Office, 88/24 Tiwanon Road, Talad Khwan Subdistrict, Mueang District, Nonthaburi Province 11000.
Telephone: +66 2590 7000
1 November 2022
Since cannabis was taken off the list of narcotic drugs, there has been an increase in the number of foods, beverages, and snacks.
According to the Immigration Act 1979, in Section 4, the definition of “a person in charge of conveyance" means a ship's master or person responsible for supervising a vehicle
For foreigners wishing to extend their stay in Thailand, in the case of being family members of a Thai national (only parents, spouses, children, adopted children, or children of spouses), the Immigration Office has determined the requirements, as follows
EN
CN
DE
JP
TH